LV11327B - Imidazodiazepine - Google Patents

Imidazodiazepine Download PDF

Info

Publication number
LV11327B
LV11327B LVP-95-59A LV950059A LV11327B LV 11327 B LV11327 B LV 11327B LV 950059 A LV950059 A LV 950059A LV 11327 B LV11327 B LV 11327B
Authority
LV
Latvia
Prior art keywords
imidazo
dihydro
mmol
oxadiazol
wurde
Prior art date
Application number
LVP-95-59A
Other languages
English (en)
Latvian (lv)
Other versions
LV11327A (lv
Inventor
Thierry Godel
Walter Hunkeler
Heinz Stadler
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LV11327A publication Critical patent/LV11327A/xx
Publication of LV11327B publication Critical patent/LV11327B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
LVP-95-59A 1994-03-16 1995-03-15 Imidazodiazepine LV11327B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH78394 1994-03-16
CH1095 1995-01-03

Publications (2)

Publication Number Publication Date
LV11327A LV11327A (lv) 1996-06-20
LV11327B true LV11327B (en) 1996-10-20

Family

ID=25683249

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-59A LV11327B (en) 1994-03-16 1995-03-15 Imidazodiazepine

Country Status (27)

Country Link
US (1) US5665718A (ko)
EP (1) EP0672666B1 (ko)
JP (1) JP2690282B2 (ko)
KR (1) KR100214800B1 (ko)
CN (1) CN1036995C (ko)
AT (1) ATE203536T1 (ko)
AU (1) AU679608B2 (ko)
BG (1) BG62210B1 (ko)
CA (1) CA2143246C (ko)
CZ (1) CZ288594B6 (ko)
DE (1) DE59509432D1 (ko)
DK (1) DK0672666T3 (ko)
ES (1) ES2160646T3 (ko)
FI (1) FI112487B (ko)
GR (1) GR3037019T3 (ko)
HU (1) HU219987B (ko)
IL (1) IL112955A (ko)
IS (1) IS4273A (ko)
LV (1) LV11327B (ko)
MA (1) MA23479A1 (ko)
NO (1) NO303731B1 (ko)
NZ (1) NZ270685A (ko)
PH (1) PH31443A (ko)
PT (1) PT672666E (ko)
RO (1) RO117698B1 (ko)
RU (1) RU2139873C1 (ko)
SK (1) SK33995A3 (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349100B (en) * 1994-11-11 1999-01-01 Hoffmann La Roche Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines
US5905176A (en) * 1998-08-28 1999-05-18 Eastman Chemical Company Process for the production of cyclobutyl halides
EP1178990B1 (en) 1999-05-12 2003-01-29 F. Hoffmann-La Roche Ag Imidazodiazepine derivative
US7160880B1 (en) * 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
US20060065608A1 (en) * 2004-09-29 2006-03-30 Choate Chris E Process and apparatus for generating useful biomass from organic waste streams
JP2008527040A (ja) * 2005-01-19 2008-07-24 メルク エンド カムパニー インコーポレーテッド アルツハイマー病の治療のためのアミノメチルベータセクレターゼ阻害剤
US8338614B2 (en) * 2005-01-19 2012-12-25 Merck, Sharp & Dohme Corp. Tertiary carbinamines having substituted heterocycles which are active as β-secretase inhibitors for the treatment of alzheimer's disease
US7595395B2 (en) * 2005-05-16 2009-09-29 Wisys Technology Foundation Gabaergic agents to treat memory deficits
GB0613693D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
CN103288834B (zh) 2006-07-10 2015-07-15 Paion英国有限公司 短效苯并二氮杂*盐及其多晶型
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
EP2190435B1 (en) 2007-08-20 2018-05-30 Evotec International GmbH Treatment of sleep disorders
WO2009024324A2 (en) * 2007-08-20 2009-02-26 Evotec Neurosciences Gmbh Treatment of sleep disorders
RU2503681C2 (ru) * 2008-09-30 2014-01-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Новое конденсированное производное аминодигидротиазина
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
SG11201407710VA (en) 2012-05-22 2015-01-29 Paion Uk Ltd Compositions comprising short-acting benzodiazepines
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
EP3363790B1 (en) 2013-09-06 2020-02-19 Aurigene Discovery Technologies Limited 1,2,4-oxadiazole derivatives as immunomodulators
AU2016230759A1 (en) * 2015-03-10 2017-09-07 Aurigene Discovery Technologies Limited 3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
CN114044760A (zh) * 2015-03-10 2022-02-15 奥瑞基尼探索技术有限公司 作为免疫调节剂的1,2,4-噁二唑和噻二唑化合物
CN109641000A (zh) 2016-04-14 2019-04-16 Paion英国有限公司 经口吸入和经鼻用的苯并二氮杂*类
WO2019061324A1 (en) 2017-09-29 2019-04-04 Curis Inc. CRYSTALLINE FORMS OF IMMUNOMODULATORS
EA202090536A1 (ru) 2017-10-11 2020-07-22 Ориджен Дискавери Текнолоджис Лимитед Кристаллические формы 3-замещенного 1,2,4-оксадиазола
CN111372584A (zh) 2017-11-03 2020-07-03 奥瑞基尼探索技术有限公司 Tim-3和pd-1途径的双重抑制剂
EP3706798A1 (en) 2017-11-06 2020-09-16 Aurigene Discovery Technologies Limited Conjoint therapies for immunomodulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151808C (da) * 1982-11-16 1988-06-20 Ferrosan As Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater
NZ210850A (en) * 1984-01-19 1988-10-28 Hoffmann La Roche Imidazodiazepine derivatives and pharmaceutical compositions
AU587802B2 (en) * 1985-03-08 1989-08-31 Ferrosan A/S Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
DK476885D0 (da) * 1985-10-17 1985-10-17 Ferrosan As Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf
US4622320A (en) * 1985-05-17 1986-11-11 As Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
US4904654A (en) * 1989-07-26 1990-02-27 Merck & Co., Inc. 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine
US4939139A (en) * 1989-07-26 1990-07-03 Merck & Co., Inc. 7-chloro-5,6-dihydro-3-(5-(1,2-dihydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5A][1,4]benzodiazepine

Also Published As

Publication number Publication date
AU679608B2 (en) 1997-07-03
EP0672666B1 (de) 2001-07-25
PT672666E (pt) 2002-01-30
NZ270685A (en) 1996-05-28
JP2690282B2 (ja) 1997-12-10
SK33995A3 (en) 1995-10-11
BG62210B1 (bg) 1999-05-31
US5665718A (en) 1997-09-09
AU1476095A (en) 1995-09-28
CA2143246C (en) 2000-08-22
IS4273A (is) 1995-09-17
KR100214800B1 (ko) 1999-08-02
JPH07258260A (ja) 1995-10-09
RU2139873C1 (ru) 1999-10-20
EP0672666A2 (de) 1995-09-20
ES2160646T3 (es) 2001-11-16
PH31443A (en) 1998-11-03
CN1111632A (zh) 1995-11-15
HU9500743D0 (en) 1995-04-28
GR3037019T3 (en) 2002-01-31
HUT71817A (en) 1996-02-28
RO117698B1 (ro) 2002-06-28
MA23479A1 (fr) 1995-10-01
NO303731B1 (no) 1998-08-24
FI112487B (fi) 2003-12-15
CZ66395A3 (en) 1995-10-18
FI951251A (fi) 1995-09-17
CA2143246A1 (en) 1995-09-17
HU219987B (hu) 2001-10-28
ATE203536T1 (de) 2001-08-15
CN1036995C (zh) 1998-01-14
NO950999L (no) 1995-09-18
IL112955A0 (en) 1995-06-29
EP0672666A3 (de) 1995-11-08
BG99505A (en) 1996-01-31
DE59509432D1 (de) 2001-08-30
RU95103921A (ru) 1996-12-10
NO950999D0 (no) 1995-03-15
LV11327A (lv) 1996-06-20
KR950032199A (ko) 1995-12-20
IL112955A (en) 1998-02-08
CZ288594B6 (cs) 2001-07-11
DK0672666T3 (da) 2001-11-12
FI951251A0 (fi) 1995-03-16

Similar Documents

Publication Publication Date Title
LV11327B (en) Imidazodiazepine
ES2234704T3 (es) Compuestos heterotriciclicos condensados, procedimiento para su preparacion y farmacos que los contienen.
DE69635922T2 (de) Tricyclische benzazepin vasopressinantagonisten
US9447100B2 (en) Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents
JP3782475B2 (ja) 三環式ジアゼピンバソプレシン拮抗薬およびオキシトシン拮抗薬
EP2834238B1 (en) Diacylglycerol acyltransferase 2 inhibitors
CS249148B2 (en) Method of new imidazodiazepine's derivatives production
EP0519307A2 (de) Tetracyclische Imidazodiazepine
MX2013003093A (es) Compuestos de imidazotriazinona.
DD299308A5 (de) Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU673814B2 (en) Imidazoquinazoline compounds and their preparation and use
JP2024512740A (ja) 例えばがんの処置のためのＳＨＰ２阻害剤としての（Ｓ）－１－（５－（（ピリジン－３－イル）チオ）ピラジン－２－イル）－４’Ｈ，６’Ｈ－スピロ［ピペリジン－４，５’－ピロロ［１，２－ｂ］ピラゾール］－４’－アミン誘導体及び同様の化合物
CN101090902B (zh) Cgrp受体拮抗剂
KR20220046592A (ko) 혈장 칼리크레인 저해제
EP0197282A1 (en) Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
NO171067B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolo (1,5-a)pyrimidiner
JP2003516994A (ja) 認知能力を向上させるための置換１，２，３−トリアゾロ［１，５−ａ］キナゾリン
DE69328976T2 (de) Antiallergisch triazolo (pyrrolo, thieno oder furano) azepinderivate
NO177749B (no) Analogifremgangsmåte ved fremstilling av 2,4,8-tri-substituerte 3H,6H-1,4,5a,8a-tetraazaace-naftylen-3,5-(4H)-dioner
HRP950125A2 (en) Imidazodiazepines
OA17143A (en) Diacylglycerol acyltransferase 2 inhibitors